Biocom, a California trade group for the life science industry, has issued awards to seven Los Angeles business leaders under 40 years old for their contributions to the local industry.
The San Diego-based Biocom on Sept. 13 announced the winners of its Third Annual Life Science Catalyst Awards. Ten of the winners were from San Diego, a major life sciences hub.
“This year’s winners, whether working tirelessly in the lab or heading their own startup, highlight the ways that the life sciences are accelerating in a way we’ve never seen before,” said Dina Lozofsky, executive director of Biocom’s Los Angeles office, in a statement.
“The Los Angeles biotech community is truly strengthened by the life-changing contributions these trailblazers are making.”
Biocom named each up-and-coming leader for their contributions to research, discovery and entrepreneurship to life science industry sectors that include pharmaceuticals, diagnostics, industrial biotech and digital health.
In Los Angeles, they include:
- Carolina Amador, president of Biotech Connection Los Angeles
- Brian Benson, director of entrepreneurship and commercialization at the California NanoSystems Institute at UCLA
- Long Cai, research biologist at the California Institute of Technology and co-founder of Spatial Genomics Inc. of Pasadena
- Joseph Dunham, co-founder and chief scientific officer of SeqOnce Biosciences Inc. of Pasadena
- Stephen Fiacco, founder and chief executive of EvoRx Technologies Inc. of Pasadena
- Leo Petrossian, chief executive of Neural Analytics Inc. of West Los Angeles
- Ryan Witt, chief operating officer of Immix Biopharma Inc. of Pico-Union
Each winner will be featured in the fall edition of a Biocom magazine and at a Biocom Board of Directors meeting in December.
Health business reporter Dana Bartholomew can be reached at firstname.lastname@example.org. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Biocom Announces New Advisory Board to Boost L.A. Biotech
- L.A. Bioscience Gets $1 Billion in Federal Research Funds, Study Finds
- $1B in Grants for Area Biomeds
- Neural Analytics Wins Federal Approval for Robotics Tech
- Summit Pushes L.A. as Bioscience Leader
- Locals Part of Broad Range on Neuroscience R&D
- Reason to Ponder Biotech’s Future in L.A.
- Local Investment Focus of SoCal Bio Conference